Bacteriological Profile and Antibiotic Resistance of Pleural Infections: A literature Review

##plugins.themes.academic_pro.article.main##

Amjad Idrissi
Abderrazak Saddari
Said Ezrari
Sohaib El Kandouni
Elmostafa Benaissa
Yassine Ben Lahlou
Mostafa Elouennass
Adil Maleb

Abstract

Pleural infection remains a medical challenge with serious consequences for the health and lives of individuals worldwide. The diagnosis of pleural effusion (PE) infection shows that the isolated micro-organisms exhibit substantial resistance to standard prescribed antibiotics. Therefore, the
selection of appropriate antibiotics for treatment should be based on microbiological findings. Understanding the microbiology of pleural infections is essential for making informed choices about antibiotic therapy. The objective of this review is to analyze studies that have attempted to identify the types of bacteria involved, antibiotic sensitivity and resistance profiles, factors associated with pleural infections. Studies showed that bacteria isolated from pleural effusion have shown increasing antibiotic resistance, which should influence the choice of empirical antimicrobial therapy.
This also highlights the importance of closely monitoring the dissemination and emergence of drug-resistant bacterial agents.

Keywords:

Pleural infection, microbiological profile, antibiotic resistance

##plugins.themes.academic_pro.article.details##

References

  1. Tian P, Qiu R, Wang M, Xu S, Cao L, Yang P, et al. Prevalence, causes, and health care burden of pleural effusions among hospitalized
  2. adults in China. JAMA Netw Open. 2021;4(8):e2120306–e2120306.
  3. Ferreiro L, Porcel JM, Valdés L. Diagnosis and management of pleural transudates. Arch Bronconeumol (English Ed. 2017;53(11):629–36.
  4. Karki A, Riley L, Mehta HJ, Ataya A. Abdominal etiologies of pleural effusion. Disease-a-Month. 2019;65(4):95–103.
  5. Hassan M, Cargill T, Harriss E, Asciak R, Mercer RM, Bedawi EO, et al. The microbiology of pleural infection in adults: a systematic
  6. review. Eur Respir J. 2019;54(3).
  7. Cargill TN, Hassan M, Corcoran JP, Harriss E, Asciak R, Mercer RM, et al. A systematic review of comorbidities and outcomes of adult
  8. patients with pleural infection. Eur Respir J. 2019;54(3).
  9. Mehta P, Rathod KG, Bhalla K, Nanda S. To study the clinical profile of children with pleural effusion at a Tertiary Care Center in North
  10. India: A prospective study. Indian J Child Health. 2017;438–41.
  11. Falguera M, Carratalà J, Bielsa S, García-Vidal C, Ruiz-González A, Chica I, et al. Predictive factors, microbiology and outcome
  12. of patients with parapneumonic effusion. Eur Respir J. 2011;38(5):1173–9.
  13. Rosenstengel A. Pleural infection-current diagnosis and management. J Thorac Dis. 2012;4(2):186.
  14. Nwagboso CI, Ekeng BE, Etiuma AU, Ochang EA, Eze JN, Echieh CP. Microbiological profile and antibiotic resistance pattern of
  15. empyema thoracis in Calabar, Nigeria. Trop Doct. 2021;51(4):523–6.
  16. Porcel JM, Gasol A, Bielsa S, Civit C, Light RW, Salud A. Clinical features and survival of lung cancer patients with pleural effusions.
  17. Respirology. 2015;20(4):654–9.
  18. Arnold DT, De Fonseka D, Perry S, Morley A, Harvey JE, Medford A, et al. Investigating unilateral pleural effusions: the role of cytology. Eur Respir J. 2018;52(5).
  19. Krishna R, Rudrappa M. Pleural Effusion. 2017;
  20. Hassan M, Patel S, Sadaka AS, Bedawi EO, Corcoran JP, Porcel JM. Recent insights into the management of pleural infection. Int J Gen
  21. Med. 2021;3415–29.
  22. Brims FJH, Lansley SM, Waterer GW, Lee YCG. Empyema thoracis: new insights into an old disease. Eur Respir Rev. 2010;19(117):220–8.
  23. Yang W, Zhang B, Zhang ZM. Infectious pleural effusion status and treatment progress. J Thorac Dis. 2017;9(11):4690.
  24. Walker SP, Morley AJ, Stadon L, De Fonseka D, Arnold DT, Medford ARL, et al. Nonmalignant pleural effusions: a prospective study of
  25. consecutive unselected patients. Chest. 2017;151(5):1099–105.
  26. Karkhanis VS, Joshi JM. Pleural effusion: diagnosis, treatment, and management. Open access Emerg Med OAEM. 2012;4:31.
  27. Menzies SM, Rahman NM, Wrightson JM, Davies HE, Shorten R, Gillespie SH, et al. Blood culture bottle culture of pleural fluid in
  28. pleural infection. Thorax. 2011;thx-2010.
  29. Davies HE, Davies RJO, Davies CWH. Management of pleural infection in adults: British Thoracic Society pleural disease guideline
  30. Thorax. 2010;65(Suppl 2):ii41–53.
  31. Mohapatra MM, Rajaram M, Mallick A. Clinical, radiological and bacteriological profile of lung abscess-an observational hospital
  32. based study. Open access Maced J Med Sci. 2018;6(9):1642.
  33. Lehtomäki AI, Nevalainen RM, Toikkanen VJ, Pohja ES, Nieminen JJ, Laurikka JO, et al. Pleural infection—an indicator of morbidity and
  34. increased burden on health care. Interact Cardiovasc Thorac Surg. 2020;31(4):513–8.
  35. Schweigert M, Solymosi N, Dubecz A, Fernández MJ, Stadlhuber RJ, Ofner D, et al. Surgery for parapneumonic pleural empyema–
  36. what influence does the rising prevalence of multimorbidity and advanced age has on the current outcome? Surg. 2016;14(2):69–
  37. Khan S, Yasin M, Muhammad M, Tareen S, Adeel M, Jan F. Culture and sensitivity patterns of the causative organisms isolated
  38. from the patient of Empyema Thoracis. Pakistan J Chest Med. 2021;27(2):80–7.
  39. Dutta V, Khyriem AB, Bora I, Barman H, Lyngdoh WV, Neigrihms S. Bacteriological profile of pleural fluid among the pediatric
  40. population in a tertiary care centre-a retrospective analysis. Int J Heal Sci Res. 2015;5(9):167–74.
  41. Porcel JM, Esquerda A, Vives M, Bielsa S. Etiology of pleural effusions: analysis of more than 3,000 consecutive thoracenteses.
  42. Arch Bronconeumol (English Ed. 2014;50(5):161–5.
  43. Wrightson JM, Wray JA, Street TL, Chapman SJ, Crook DWM, Rahman NM. S113 Predictors of bacterial ‘load’in pleural infection.
  44. BMJ Publishing Group Ltd; 2014.
  45. Bedawi EO, Hassan M, McCracken D, Rahman NM. Pleural infection: a closer look at the etiopathogenesis, microbiology and role of
  46. antibiotics. Expert Rev Respir Med. 2019;13(4):337–47.
  47. Psallidas I, Kanellakis NI, Bhatnagar R, Ravindran R, Yousuf A, Edey AJ, et al. A pilot feasibility study in establishing the role of
  48. ultrasound-guided pleural biopsies in pleural infection (the AUDIO study). Chest. 2018;154(4):766–72.
  49. Maskell NA, Batt S, Hedley EL, Davies CWH, Gillespie SH, Davies RJO. The bacteriology of pleural infection by genetic and standard
  50. methods and its mortality significance. Am J Respir Crit Care Med. 2006;174(7):817–23.
  51. Remic. Référentiel en microbiologie médicale. Remic de la Société française de microbiologie (éd), 7e édition. 2022. 365–371 p.
  52. Khodeary A, Mohamed T, Alkhayat K, Sayed S. Bacterial Profile and Antibiotics Susceptibility Pattern of Pleural Effusion Isolates from
  53. Sohag University Hospital. Egypt J Med Microbiol. 2022;31(3):29–35.
  54. Teklehymanot F, Legese MH, Desta K. Bacterial profile and their antimicrobial resistance patterns from body fluids at Tikur
  55. Anbesa Specialized Hospital, Addis Ababa, Ethiopia. Biol Med. 2017;9(05):408.
  56. Wayne PA. Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing: 20th informational supplement. CLSI Doc M100-S20. 2010;
  57. Insa R, Marín M, Martín A, Martín-Rabadán P, Alcalá L, Cercenado E, et al. Systematic use of universal 16S rRNA gene polymerase chain reaction (PCR) and sequencing for processing pleural effusions improves conventional culture techniques. Medicine (Baltimore).
  58. ;91(2):103–10.
  59. Chalmers JD, Singanayagam A, Scally C, Fawzi A, Murray MP, Hill AT.Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community acquired pneumonia. Thorax. 2009;
  60. Bedawi EO, Hassan M, Rahman NM. Recent developments in the management of pleural infection: a comprehensive review. Clin
  61. Respir J. 2018;12(8):2309–20.
  62. Mohanty S, Kapil A, Das BK. Bacteriology of parapneumonic pleural effusions in an Indian hospital. Trop Doct. 2007;37(4):228–9.
  63. Dorobăţ OM, Moisoiu A, Tălăpan D. Bacteria isolated from pleural fluid and their resistance to antimicrobials. Pneumologia.
  64. ;55(2):47–51.
  65. Najah L, Jabri H, El Khattabi W, Afif H. Profil bactériologique des pleurésies purulentes. Rev Mal Respir. 2019;36:A151.
  66. Vishalakshi B, Hanumanthappa P, Krishna S. A study on aerobic bacteriological profile of sterile body fluids. Int J Curr Microbiol
  67. Appl Sci. 2016;5(5):120–6.
  68. Alelign D, Ameya G, Siraj M. Bacterial pathogens, drug-resistance profile and its associated factors from patients with suspected
  69. peritonitis in Southern Ethiopia. Infect Drug Resist. 2021;4107–17.